Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | PLEC | Q15149 | 1/20 | 0.63 |
| ▸ | HSD17B3 | P37058 | 6/20 | 0.59 |
| ▸ | ESR1 | P03372 | 3/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | CDC25C | P30307 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | ALPG | P10696 | 1/20 | 0.52 |
| ▸ | GNG2 | P59768 | 1/20 | 0.52 |
| ▸ | GNB1 | P62873 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12909301 | 0.83 | USP2 (0.68) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL21151072 | 0.82 | KMT2A (0.60) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL13320808 | 0.81 | KMT2A (0.59) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL12679617 | 0.81 | KMT2A (0.59) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL14044262 | 0.81 | USP2 (0.77) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL10030600 | 0.80 | USP2 (0.64) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL5468848 | 0.80 | USP2 (0.71) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL8427558 | 0.79 | USP2 (0.64) | USP2MEN1KMT2APOLBATM | |
| SCHEMBL16804613 | 0.79 | KDM4E (0.56) | USP2MEN1KMT2APOLBESR1 | |
| SCHEMBL12909281 | 0.79 | USP2 (0.62) | USP2MEN1KMT2APOLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023235535-A1 | FLUORESCENTLY-ACTIVE FREE RADICAL TAGS FOR SIMULTANEOUS GLYCAN QUANTITATION AND CHARACTERIZATION | MONTCLAIR STATE UNIVERSITY (US) | 2023-12-07 | — | — | WO | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8748480-B2 | Methods for treating opioid tolerance | UNIVERSITY OF ROCHESTER (US) | 2014-06-10 | — | — | US | disclosed |
| US-8748480-B2 | Methods for treating opioid tolerance | UNIVERSITY OF ROCHESTER (US) | 2014-06-10 | — | — | US | disclosed |
| US-20130116313-A1 | Compositions and Methods for Inhibiting G Protein Signaling | UNIVERSITY OF ROCHESTER (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116313-A1 | Compositions and Methods for Inhibiting G Protein Signaling | UNIVERSITY OF ROCHESTER (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130018195-A1 | FLUORESCENT CELL MARKERS | KODE BIOTECH LIMITED (NZ) | 2013-01-17 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| EP-2147310-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | University of Rochester (US) | 2010-01-27 | — | — | EP | disclosed |
| US-20090221691-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090221691-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-09-03 | — | — | US | disclosed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | disclosed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018195-A1 | FLUORESCENT CELL MARKERS | CD69, SPTLC2, CD4 | USP2 1567/4885MEN1 1613/4885KMT2A 3566/4885 |
| US-20130116313-A1 | Compositions and Methods for Inhibiting G Protein Signaling | GNAI3, GNAI1, GNAI2 | USP2 2380/4885MEN1 2590/4885KMT2A 4380/4885 |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI1, GNAI3, GNAI2 | USP2 1478/4885MEN1 3515/4885KMT2A 4394/4885 |
| US-20090221691-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI3, GNAI1, GNAI2 | USP2 2364/4885MEN1 2570/4885KMT2A 4338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.